ÂÜÀòÂÒÂ×

Anthony George has been in the field of personalized cancer diagnostics and disease monitoring since 2011. From 2011 to 2016, they were a Research Engineer and PhD Student at Lund University. In 2016, they became Co-Founder and CTO of SAGA Diagnostics AB, a company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). Their mission is to improve precision cancer medicine, provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.

Anthony George holds a Master's Degree in Medical Science from Lund University, a PhD Student in Oncology and Cancer Biology from Lund University, and a Bachelor's Degree in Computer Science and Engineering from The University of Toledo.